Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
Kidney International. Supplement
|
November 1, 1989
Evidence for a nutritional need for glutamine in catabolic patients
P Fürst, S Albers, P Stehle
Metabolism: Clinical and Experimental
|
August 1, 1989
Availability of glutamine supplied intravenously as alanylglutamine
P Fürst, S Albers, P Stehle
Trends in Neurosciences
|
May 18, 2001
New insights into progressive supranuclear palsy
D S Albers, S J Augood
Diabetologia
|
December 29, 2000
Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus
T Heitzer, K Krohn, S Albers, et al.
The Journal of Physiology
|
November 30, 2018
The role of submaximal exercise-induced skeletal muscle remodelling in heart failure with reduced ejection fraction patients
Anish Engineer, Shawn S Albers, Andrew S Kucey
Zeitschrift Fur Ernahrungswissenschaft
|
September 1, 1989
[A cystine-containing short-chain peptide as a potential cystine source for parenteral nutrition]
L Pollack, P Stehle, S Albers, et al.
The Journal of Nutrition
|
December 1, 1988
In vivo utilization of cystine-containing synthetic short-chain peptides after intravenous bolus injection in the rat
P Stehle, S Albers, L Pollack, et al.
Brain Research
|
April 29, 1996
Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP
D S Albers, G D Zeevalk, P K Sonsalla
Amino Acids
|
January 1, 1999
Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism
P K Sonsalla, D S Albers, G D Zeevalk
Brain Research
|
June 17, 1998
Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice
L Y Moy, D S Albers, P K Sonsalla
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
Kidney International. Supplement
|
November 1, 1989
Evidence for a nutritional need for glutamine in catabolic patients
P Fürst, S Albers, P Stehle
Metabolism: Clinical and Experimental
|
August 1, 1989
Availability of glutamine supplied intravenously as alanylglutamine
P Fürst, S Albers, P Stehle
Trends in Neurosciences
|
May 18, 2001
New insights into progressive supranuclear palsy
D S Albers, S J Augood
Diabetologia
|
December 29, 2000
Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus
T Heitzer, K Krohn, S Albers, et al.
The Journal of Physiology
|
November 30, 2018
The role of submaximal exercise-induced skeletal muscle remodelling in heart failure with reduced ejection fraction patients
Anish Engineer, Shawn S Albers, Andrew S Kucey
Zeitschrift Fur Ernahrungswissenschaft
|
September 1, 1989
[A cystine-containing short-chain peptide as a potential cystine source for parenteral nutrition]
L Pollack, P Stehle, S Albers, et al.
The Journal of Nutrition
|
December 1, 1988
In vivo utilization of cystine-containing synthetic short-chain peptides after intravenous bolus injection in the rat
P Stehle, S Albers, L Pollack, et al.
Brain Research
|
April 29, 1996
Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP
D S Albers, G D Zeevalk, P K Sonsalla
Amino Acids
|
January 1, 1999
Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism
P K Sonsalla, D S Albers, G D Zeevalk
Brain Research
|
June 17, 1998
Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice
L Y Moy, D S Albers, P K Sonsalla
Page
of 7